Drugs / alpha-lactalbumin-oleic acid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07698886 | Jul 2026 → Aug 2027 expected | human papilloma virus infection | KTH Biopharma | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | alpha-lactalbumin-oleic acid | “Geniwa gel contains alpha lactalbumin-oleic acid 5%” NCT07698886 ↗ |
| Known as | HAMLET | “BACKGROUND: We studied the effect on skin papillomas of topical application of a complex of alpha-lactalbumin and oleic acid (often referred to as human alpha-lactalbumin made...” PMID 15215482 ↗ Jun 2004 |
| Route | Topical | “topical application of a complex of alpha-lactalbumin and oleic acid” PMID 15215482 ↗ Jun 2004 |